Evidence map›Paper›PMID 42389557›Full record

ArticleEcancermedicalscience2026

Genetic association of

Kevin Guzmán, Vanessa Pabón, Andrés Angulo, Luis E Bravo, Arsenio Hidalgo, Carol Rosero, Alvaro Pazos

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin GuzmánGrupo Salud Publica, Centro de Estudios en Salud, Universidad de Nariño, Pasto 520001, Colombia.
Vanessa PabónGrupo Salud Publica, Centro de Estudios en Salud, Universidad de Nariño, Pasto 520001, Colombia.
Andrés AnguloGrupo Salud Publica, Centro de Estudios en Salud, Universidad de Nariño, Pasto 520001, Colombia.
Luis E BravoRegistro Poblacional de Cáncer de Cali, Department of Pathology, School of Medicine, Universidad del Valle, Cali 760043, Colombia.
Arsenio HidalgoGrupo Salud Publica, Centro de Estudios en Salud, Universidad de Nariño, Pasto 520001, Colombia.
Carol RoseroFacultad de Medicina, Universidad Cooperativa de Colombia, Pasto 520001, Colombia.
Alvaro PazosGrupo Salud Publica, Centro de Estudios en Salud, Universidad de Nariño, Pasto 520001, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) incidence varies markedly across Colombia. Host genetic polymorphisms in cytokine genes modulate the inflammatory response to Helicobacter pylori and may influence disease progression. Objective: To evaluate IL-1B-511, IL-10-1082 and TNF-A-308 polymorphisms and their association with gastric precursor lesions in Colombian populations with contrasting GC risk. Methods: We studied 160 dyspeptic patients from Túquerres (high risk) and 105 from Tumaco (low risk). Gastric lesions were classified using the Sydney system. Cytokine polymorphisms were genotyped by polymerase chain reaction-restriction fragment length polymorphism and sequencing. Associations were assessed using logistic regression. Results: The IL-1B-511TT and IL-10-1082AA genotypes were significantly more frequent in Túquerres than in Tumaco (p < 0.05). Individuals carrying the IL-10-1082AG genotype had a significantly higher risk of gastric atrophy (odds ratio = 5.45; 95% confidence interval, 1.0-30.59). Conclusion: IL-10-1082AG is associated with increased risk of gastric atrophy in high-risk Colombian populations, supporting its potential role as a biomarker of GC susceptibility.

Indexed as

gastric atrophygastric cancergastric cancer biomarkersHelicobacter pyloriinterleukin 10interleukin 1β

Identifiers

PMID42389557
PMCPMC13319349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.